COO
Cooper Companies Inc (COO)
Healthcare • NASDAQ • $60.00-1.82%
- Symbol
- COO
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $60.00
- Daily Change
- -1.82%
- Market Cap
- $11.71B
- Trailing P/E
- 29.85
- Forward P/E
- 11.95
- 52W High
- $89.83
- 52W Low
- $59.68
- Analyst Target
- $91.07
- Dividend Yield
- N/A
- Beta
- 0.89
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group…
Company websiteResearch COO on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.